Carregant...
Proton Pump Inhibitors are Risk Factors for Viral Infections: Even for COVID-19?
During the ongoing pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), more attention should be paid to the balance of risks and benefits associated with proton pump inhibitors for the following reasons. One of the main functions of gastric juice is to inactivate swallowed micr...
Guardat en:
| Publicat a: | Clin Drug Investig |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer International Publishing
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7417108/ https://ncbi.nlm.nih.gov/pubmed/32779119 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-020-00963-x |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|